Population Pharmacokinetics of CC-122

Yiming Cheng,1 Jian Chen,2 Michael Pourdehnad,3 Simon Zhou,1 Yan Li1 1Clinical Pharmacology & Pharmacometrics, Bristol Myers Squibb, Summit, NJ, USA; 2Non-Clinical Research & Development, Bristol Myers Squibb, Summit, NJ, USA; 3Early Clinical Development, Bristol Myers Squibb, San Francisco, CA, USACorrespondence: Yan LiClinical Pharmacolog

read more


Whistleblowing as an anti-corruption strategy in health and pharmaceutical organizations in low- and middle-income countries: a scoping review

footjoy weste herren Background Whistleblowing can bring suspected wrongdoing to the attention of someone who is in the position to rectify the problem.Whistleblowing research can help improve effectiveness of anti-corruption efforts in the health sector.Objective The objective of this scoping review is to understand the extent and type of evidence

read more

Relationship between hyperglycemia, antioxidant capacity and some enzymatic and non-enzymatic antioxidants in African patients with type 2 diabetes

Abstract Background and purpose Studies demonstrate that free radicals are involved in the pathogenesis of diabetic complications.The aim of this study was to determine the implication of total antioxidant capacity (TAC) and some enzymatic and non-enzymatic antioxidants as suitable biomarkers of diabetic complications risk factors.Methods A total o

read more